GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...
Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback